Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases

Detalles Bibliográficos
Autores principales: Otiniano, Armelle, van de Wyngaert, Zoe, Brissot, Eolia, Dulery, Rémy, Gozlan, Joel, Daguenel, Anne, Abi Aad, Yasmine, Ricard, Laure, Stocker, Nicolas, Banet, Anne, Bonnin, Agnes, Alsuliman, Tamim, Marjanovic, Zora, Schnuriger, Aurélie, Coppo, Paul, Legrand, Ollivier, Lacombe, Karine, Mohty, Mohamad, Malard, Florent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734768/
https://www.ncbi.nlm.nih.gov/pubmed/36481838
http://dx.doi.org/10.1038/s41409-022-01894-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734768/
https://www.ncbi.nlm.nih.gov/pubmed/36481838
http://dx.doi.org/10.1038/s41409-022-01894-1

Ejemplares similares